Patent for Copaxone ceased in 2014 , but pesumbaly the two companies are working together as NSB would need to source Copaxone part of the product or the news story attached (dated 2018) might also explain https://www.fiercepharma.com/pharma/facing-generics-from-mylan-and-novartis-teva-loses-patent-appeal-copaxone "Teva's patent failure gives long-acting Copaxone generics free rein"
- Forums
- ASX - By Stock
- NSB
- Ann: NSB files new patent
Ann: NSB files new patent, page-13
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.928M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.0¢ | $17.32K | 403.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 305000 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 94677 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 305000 | 0.040 |
2 | 232982 | 0.038 |
2 | 225000 | 0.036 |
1 | 200000 | 0.035 |
2 | 249400 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 94677 | 1 |
0.045 | 20000 | 1 |
0.046 | 336849 | 2 |
0.048 | 279261 | 1 |
0.050 | 201085 | 2 |
Last trade - 14.34pm 16/08/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |